CORDIS
EU research results

CORDIS

English EN

Protecting patients with enhanced susceptibility to infections

Project information

Grant agreement ID: 713660

Status

Ongoing project

  • Start date

    1 September 2016

  • End date

    31 August 2021

Funded under:

H2020-EU.1.3.4.

  • Overall budget:

    € 3 348 480

  • EU contribution

    € 1 674 240

Coordinated by:

ACADEMISCH ZIEKENHUIS GRONINGEN

Netherlands

Objective

The Microbes in Health and Disease research programme at the University Medical Center Groningen (UMCG) proposes the Doctoral Training Programme PRONKJEWAIL (‘a real gem’) in the field of hospital care and infection. The specific training objective is ‘protecting patients with enhanced susceptibility to infections’. PRONKJEWAIL will recruit 16 international ESRs, who will be trained in research, transferable skills, and network and capacity building. They will be guided by experienced supervisors from the departments of Medical Microbiology, Internal Medicine, Intensive Care, Clinical Pharmacy and Pharmacology, Rheumatology and Immunology, Surgery, Cell Biology, and Pharmacoepidemiology and Pharmacoeconomics at the UMCG.

26 partner organisations, including 14 private sector partners, are committed to support ESR training via mentoring, courses and secondments. Research training builds on four Pillars: 1) vaccines and primary prevention; 2) personalized detection and infection prevention; 3) iatrogenic influence on the microbiome and 4) personalized therapy/stewardship. Each Pillar integrates fundamental, translational and clinical/epidemiological training projects. The high exposure to fundamental, translational and clinical research in academia and industry will increase the ESRs future problem-solving capabilities.

Further, ESRs will learn to value mobility through internships at international partner organizations. By providing an excellent scientific working environment PRONKJEWAIL will directly impact on hospital care and, ultimately, it will contribute to enhanced public health. By providing excellent training, PRONKJEWAIL will develop new talent within the next generation of medical researchers thereby strengthening the European Research Area.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

ACADEMISCH ZIEKENHUIS GRONINGEN

Address

Hanzeplein 1
9713 Gz Groningen

Netherlands

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 674 240

Partners (26)

KAROLINSKA INSTITUTET

Sweden

UNIVERSITETET I BERGEN

Norway

VISMEDERI SRL

Italy

THE UNIVERSITY OF LIVERPOOL

United Kingdom

MSD BV

Netherlands

QUEEN MARGARET UNIVERSITY, EDINBURGH

United Kingdom

EDINBURGH MOLECULAR IMAGING LIMITED

United Kingdom

Universitätsklinikum Tübingen

Germany

Check-Points

France

National Enterovirus Reference Center

France

Labhelp International BV

Netherlands

COPAN

Italy

ThermoFisher Scientific

Netherlands

ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON

Greece

STICHTING WETSUS, EUROPEAN CENTRE OF EXCELLENCE FOR SUSTAINABLE WATER TECHNOLOGY

Netherlands

Institute of Photonic Technology Leibniz

Germany

KING'S COLLEGE LONDON

United Kingdom

CHR. HANSEN A/S

Denmark

NUTRICIA RESEARCH BV

Netherlands

THE UNIVERSITY OF ADELAIDE

Australia

UCB-Pharma

United Kingdom

JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG

Germany

University Chest Clinic Lasi

Romania

MAD multimedia

Netherlands

GILEAD SCIENCES INC

United States

Integrated Disease Management Corporation bv

Netherlands

Project information

Grant agreement ID: 713660

Status

Ongoing project

  • Start date

    1 September 2016

  • End date

    31 August 2021

Funded under:

H2020-EU.1.3.4.

  • Overall budget:

    € 3 348 480

  • EU contribution

    € 1 674 240

Coordinated by:

ACADEMISCH ZIEKENHUIS GRONINGEN

Netherlands